We are live on !
Find out more
AGM
Alpine Global Management Portfolio holdings
AUM
$615M
Turnover
67.3%
1-Year Est. Return
34.28%
This Fund
S&P 500
This Quarter Est. Return
+30.8%
1 Year Est. Return
+34.28%
3 Year Est. Return
+148.67%
5 Year Est. Return
+161.73%
10 Year Est. Return
+891.97%
AUM
$615M
AUM Growth
-$52.6M
(-7.9%)
Cap. Flow
-$3.04M
Cap. Flow % of AUM
Cap. Flow %
-0.49%
Top 10 Holdings %
Top 10 Hldgs %
62.88%
Holding
367
New
155
Increased
30
Reduced
63
Closed
92
Avg Time Held
Equity + Options
0.4
years
Top 10 Avg Time Held
Equity + Options
1.6
years
Top 20 Avg Time Held
Equity + Options
0.9
years
Avg Time Held Equity only
0.4
years
Top 10 Avg Time Held Equity only
1.6
years
Top 20 Avg Time Held Equity only
0.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EntrepreneurShares Series Trust ERShares Private-Public Crossover ETF
XOVR
|
+$47.8M |
| 2 |
SpaceX
SPCX
|
+$43.2M |
| 3 |
Bloom Energy
BE
|
+$33.6M |
| 4 |
Credo Technology Group
CRDO
|
+$26.8M |
| 5 |
Warner Bros
WBD
|
+$8.32M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Immunovant
IMVT
|
+$38.4M |
| 2 |
KKR & Co
KKR
|
+$15M |
| 3 |
Blue Owl Capital
OWL
|
+$14.8M |
| 4 |
Apollo Global Management
APO
|
+$14.7M |
| 5 |
Ares Management
ARES
|
+$14.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 28.03% |
| 2 | Industrials | 21.92% |
| 3 | Technology | 12.25% |
| 4 | Healthcare | 11.36% |
| 5 | Consumer Discretionary | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
251
Oyster Enterprises II Acquisition Corp Rights
OYSER
| $27K | ﹤0.01% |
245,295
| – | – |
2025 Q3
3 quarters
|
|
252
PUT
Delta Air Lines
DAL
$52.7B
| $26.7K | ﹤0.01% |
+200
| New | +$15.1K |
2026 Q2
0 quarters
|
|
253
Spring Valley Acquisition Corp IV Warrants
SVIVW
| $25K | ﹤0.01% |
+25,000
| New | +$22.6K |
2026 Q2
0 quarters
|
|
254
PUT
SiriusXM
SIRI
$9.8B
| $24.8K | ﹤0.01% |
+450
| New | +$12.1K |
2026 Q2
0 quarters
|
|
255
Drugs Made In America Acquisition II Corp Right
DMIIR
| $24K | ﹤0.01% |
300,000
| – | – |
2025 Q4
2 quarters
|
|
256
Archimedes Tech SPAC Partners III Warrant
ARCIW
$2.2M
| $20.1K | ﹤0.01% |
40,200
+2,700
| +7% | +$1.47K |
2026 Q1
1 quarter
|
|
|
257
PUT
DELISTED
Warner Bros
WBD
| $18K | ﹤0.01% |
+1,000
| New | +$27.1K |
2026 Q2
0 quarters
|
|
258
Perimeter Acquisition Corp I Warrant
PMTRW
$5.43M
| $17K | ﹤0.01% |
+18,842
| New | +$13.7K |
2026 Q2
0 quarters
|
|
259
PUT
Hims & Hers Health
HIMS
$6.46B
| $14K | ﹤0.01% |
2,000
| – | – |
2026 Q1
1 quarter
|
|
260
CALL
Baidu
BIDU
$26B
| $13.9K | ﹤0.01% |
+14
| New | +$1.73K |
2026 Q2
0 quarters
|
|
261
Collective Acquisition Corp Warrants
CCAQW
| $13.7K | ﹤0.01% |
+35,108
| New | +$11.7K |
2026 Q2
0 quarters
|
|
262
CALL
iShares Ethereum Trust ETF
ETHA
$7.35B
| $12.5K | ﹤0.01% |
+135
| New | +$6.29K |
2026 Q2
0 quarters
|
|
263
CALL
iShares S&P 100 ETF
OEF
$20B
| $10.9K | ﹤0.01% |
+1
| New | +$358 |
2026 Q2
0 quarters
|
|
264
CALL
ZoomInfo Technologies
GTM
$1.27B
| $10.5K | ﹤0.01% |
+1,717
| New | +$7.72K |
2026 Q2
0 quarters
|
|
265
CALL
Alta Equipment Group
ALTG
$241M
| $8.75K | ﹤0.01% |
+500
| New | +$3.35K |
2026 Q2
0 quarters
|
|
266
DELISTED
Cohen & Steers Quality Income Realty Fund Inc Rights exp July 15 2026
RQI.RT
| $8.1K | ﹤0.01% |
+543,601
| New | +$9.5K |
2026 Q2
0 quarters
|
|
|
267
PUT
ZoomInfo Technologies
GTM
$1.27B
| $8.02K | ﹤0.01% |
+100
| New | +$450 |
2026 Q2
0 quarters
|
|
268
PUT
CleanSpark
CLSK
$1.97B
| $4.5K | ﹤0.01% |
600
| – | – |
2026 Q1
1 quarter
|
|
269
CALL
Uranium Energy
UEC
$3.82B
| $4.5K | ﹤0.01% |
+1,000
| New | +$13.4K |
2026 Q2
0 quarters
|
|
270
Aurora Innovation Warrant
AUROW
$9.16M
| $4K | ﹤0.01% |
12,500
| – | – |
2021 Q4
18 quarters
|
|
271
Starling Oncology Warrant
STLNW
$2.27M
| $1.02K | ﹤0.01% |
25,024
| – | – |
2020 Q3
23 quarters
|
|
272
Grab Holdings Warrant
GRABW
$247K
| $801 | ﹤0.01% |
17,800
| – | – |
2021 Q4
18 quarters
|
|
273
PUT
Sinclair Inc
SBGI
$926M
| $496 | ﹤0.01% |
+200
| New | +$2.88K |
2026 Q2
0 quarters
|
|
274
PUT
Algoma Steel
ASTL
$504M
| $293 | ﹤0.01% |
4
-25
| -86% | -$120 |
2026 Q1
1 quarter
|
|
|
WGSWW
275
DELISTED
GeneDx Holdings Warrant
WGSWW
| $58 | ﹤0.01% |
20,000
| – | – |
2021 Q1
21 quarters
|
|
Similar funds
OL
Alpine Global Management's Q2 2026 Portfolio in Review
As of Q2 2026, Alpine Global Management held 367 positions worth $615M, down 7.9% from $668M the previous quarter. Its ten largest holdings account for 63% of the portfolio.
Alpine Global Management's Q2 2026 filing shows 155 new, 30 increased, 63 reduced and 92 closed positions. Its largest new stake was EntrepreneurShares Series Trust ERShares Private-Public Crossover ETF: 2,500,100 shares worth $52.6M. The largest sale was Immunovant, an estimated $38.4M.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, down from 30% a quarter earlier, followed by Industrials and Technology.
- Alpine Global Management's largest Q2 2026 buy was EntrepreneurShares Series Trust ERShares Private-Public Crossover ETF: 2,500,100 shares worth $52.6M.
- Alpine Global Management added most to Warner Bros in Q2 2026, an estimated $8.32M increase.
- Alpine Global Management's biggest Q2 2026 reduction was Immunovant, cutting an estimated $38.4M.
- Alpine Global Management fully exited KKR & Co in Q2 2026, selling an estimated $15M.
- Alpine Global Management's ten largest holdings make up 63% of its $615M portfolio in Q2 2026.
- Alpine Global Management opened 155 new positions and closed 92 in Q2 2026.
- Alpine Global Management's portfolio value fell 7.9% quarter-over-quarter to $615M.
Based on Alpine Global Management's 13F filing for Q2 2026, filed 14 Aug 2026.